Groowe / Newsroom / NUVL

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NUVL News

Nuvalent, Inc. Class A Common Stock

Nuvalent to Participate in the UBS 2025 Virtual Oncology Day

prnewswire.com Sep 24, 2025 12:35 PM

Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025

prnewswire.com Sep 8, 2025 11:38 AM